ArticleCancer chemotherapy and pharmacology2020

Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation.

Yoriko Yamashita-Kashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.